This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!
Modified cold drug may combat SARS, study suggests
German researchers report a model of a key SARS protein and say the experimental cold drug AG7088 could block viral replication. Pfizer developed AG7088, now in rhinovirus trials, with Fauci calling the work a step toward antiviral targets though much remains to prove clinical effectiveness against SARS. The study notes 7400+ global SARS cases and at least 580 deaths, highlighting the potential yet distant path to a usable medicine.
MENTIONED IN THIS ARTICLE
Washington
Germany
Science
Pfizer Inc
Tony Fauci
Institute For Allergy and Infectious Diseases
Fauci
Pfizer
Peter B. Carr
Corr
Rolf Hilgenfeld
University of Luebeck